Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Long-Term Investments (2019 - 2021)

Purple Biotech has reported Long-Term Investments over the past 2 years, most recently at $187000.0 for Q4 2021.

  • Quarterly Long-Term Investments changed N/A to $187000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $187000.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $187000.0 for FY2021, N/A changed from the prior year.
  • Long-Term Investments was $187000.0 for Q4 2021 at Purple Biotech, down from $2.0 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $2.0 million in Q4 2019 and troughed at $187000.0 in Q4 2021.